कृपया अन्य खोज का प्रयास करें
TransCode Therapeutics, Inc., a ribonucleic acid (RNA) oncology company, focuses on the development and commercialization of drugs and diagnostics for treating and identifying various cancers. Its lead therapeutic candidate is TTX-MC138 that targets microRNA-10b, a master regulator of metastatic cell viability in a range of cancers, including breast, pancreatic, ovarian, colon cancer, glioblastomas, and others. The company is also developing TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; and TTX-siLIN28B, an siRNA-based inhibitor of RNA-binding protein LIN28B. In addition, the company developing TTX-RIGA, an RNA- based agonist of the retinoic acid-inducible gene I targeting activation of innate immunity in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines that activate cytotoxic immune responses against tumor cells. TransCode Therapeutics, Inc. was incorporated in 2016 and is based in Boston, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Anna Moore | 61 | 2016 | Co-Founder, Scientific Advisor & Member of Scientific Advisory Board |
Dejan Juric | - | 2021 | Member of Advisory Board |
Raghu Kalluri | - | - | Member of Advisory Board |
Oliver Steinbach | - | - | Member of Advisory Board |
G. Susan Srivatsa | - | - | Member of Advisory Board |
Keith T. Flaherty | 53 | - | Member of Advisory Board |
George Calin | - | - | Member of Advisory Board |
Raul Mostoslavsky | - | - | Member of Advisory Board |
Magda Marquet | 65 | 2021 | Independent Director |
Erik Manting | 53 | 2020 | Independent Director |
Betsabeh Madani Hermann | - | - | Member of Advisory Board |
Lubomir Nechev | - | 2021 | Member of Advisory Board |
Philippe P. Calais | 65 | 2018 | Executive Chairman of the Board |
Dmitry Samarsky | 57 | - | Member of Advisory Board |
Mehmet Yigit | - | - | Member of Advisory Board |
Jerome M. Lewis | 75 | - | Member of Advisory Board |
John B. Henneman | 62 | - | Member of Advisory Board |
Frank J. Slack | - | 2022 | Member of Advisory Board |
Thomas A. Fitzgerald | 72 | 2018 | Interim CEO, CFO, President, VP of Administration & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है